DNAJC17P1

Across TCGA pan-cancer cohorts, DNAJC17P1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of DNAJC17P1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where DNAJC17P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types DNAJC17P1 is over-expressed in tumor.

COAD, BLCA, and ESCA are the cancer types where DNAJC17P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in DNAJC17P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.080	.008	4	view →
BLCA	Female	All	+0.043	.022	4	view →
ESCA	All	II,III,IV	+0.060	.026	2	view →
KIRP	Male	All	+0.019	.029	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

DNAJC17P1–COAD

Open the COAD breakdown →